Cohance Lifesciences Limited (NSE:COHANCE)
India · Delayed Price · Currency is INR 870.00
-9.10 (-1.04%)
Oct 1, 2025, 3:30 PM IST
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 333.02 billion as of October 2, 2025. Its market cap has increased by 8.30% in one year.
Market Cap
333.02B
Enterprise Value
334.45B
Revenue
12.59B
Ranking
n/a
PE Ratio
92.65
Stock Price
870.00
Market Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 333.02B, an increase of 987,957.25%. That is a compound annual growth rate of 421.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2025 | 333.02B | 14.88% |
| Dec 31, 2024 | 289.89B | 57.55% |
| Dec 29, 2023 | 184.00B | 46.05% |
| Dec 30, 2022 | 125.98B | 0.33% |
| Dec 31, 2021 | 125.56B | 9.05% |
| Dec 31, 2020 | 115.14B | 341,510.23% |
| Mar 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,813.26B |
| Divi's Laboratories | 1,512.51B |
| Cipla | 1,201.94B |
| Apollo Hospitals Enterprise | 1,070.33B |
| Mankind Pharma | 1,016.21B |
| Zydus Lifesciences | 998.28B |
| Fortis Healthcare | 732.88B |
| Alkem Laboratories | 646.73B |